Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 14/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14665048 | 1.00 | TYMP (0.59) | TYMPADORA1NT5EADORA3 | |
| SCHEMBL30002219 | 0.91 | TYMP (0.56) | TYMPADORA1 | |
| SCHEMBL1081208 | 0.89 | TYMP (0.47) | TYMPADORA1NT5EADORA3 | |
| SCHEMBL14665042 | 0.85 | ADORA2A (0.53) | ADORA1ADORA3 | |
| SCHEMBL14665046 | 0.85 | ADORA2A (0.53) | ADORA1ADORA3 | |
| SCHEMBL1066408 | 0.85 | ADORA2A (0.53) | ADORA1ADORA3 | |
| SCHEMBL29657013 | 0.82 | TYMP (0.46) | TYMPADORA1NT5E | |
| SCHEMBL9218371 | 0.81 | TYMP (0.44) | TYMPADORA1ADORA3 | |
| SCHEMBL9239003 | 0.80 | TYMP (0.49) | TYMPADORA1ADORA3 | |
| SCHEMBL26781527 | 0.80 | TYMP (0.44) | TYMPADORA1NT5EADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362203-B2 | Non-natural peptides as models for the development of antibiotics | WAYNE STATE UNIVERSITY (US) | 2013-01-29 | — | — | US | disclosed |
| US-20110021748-A1 | Non-Natural Peptides as Models for the Development of Antibiotics | WAYNE STATE UNIVERSITY (US) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021748-A1 | Non-Natural Peptides as Models for the Development of Antibiotics | MRPL21, SPOUT1, EMG1 | TYMP 3493/4885ADORA1 3010/4885NT5E 3034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.